Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
Dimitri Poddighe,1,2 Elena Kovzel2 1Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, 010000, Kazakhstan; 2Clinical Academic Department of Pediatrics, University Medical Center (UMC), Nur-Sultan, 010000, KazakhstanCorrespondence: Dimitri Poddighe Email dimitri.poddighe@nu...
Main Authors: | Poddighe D, Kovzel E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-12-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-anti-type-2-inflammation-biologic-therapy-on-covid-19-clinic-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Evidence-Based Approach of Biologic Therapy in Bronchial Asthma
by: Adnan Liaqat, et al.
Published: (2023-06-01) -
Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction
by: Ramphul M, et al.
Published: (2021-05-01) -
Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction [Corrigendum]
by: Ramphul M, et al.
Published: (2021-07-01) -
Elaborate biologic approval process delays care of patients with moderate-to-severe asthma
by: Esha Sehanobish, PhD, et al.
Published: (2023-05-01) -
Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
by: Erminia Ridolo, et al.
Published: (2020-10-01)